94 related articles for article (PubMed ID: 34033880)
1. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
[TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
MacCallum DM; Coste A; Ischer F; Jacobsen MD; Odds FC; Sanglard D
Antimicrob Agents Chemother; 2010 Apr; 54(4):1476-83. PubMed ID: 20086148
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.
Gamarra S; Rocha EM; Zhang YQ; Park S; Rao R; Perlin DS
Antimicrob Agents Chemother; 2010 May; 54(5):1753-61. PubMed ID: 20194694
[TBL] [Abstract][Full Text] [Related]
4. Adhesive and biofilm-forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins.
Fattouh N; Husni R; Finianos M; Bitar I; Khalaf RA
Mycoses; 2024 Jun; 67(6):e13750. PubMed ID: 38813959
[TBL] [Abstract][Full Text] [Related]
5. Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.
Souza AC; Fuchs BB; Pinhati HM; Siqueira RA; Hagen F; Meis JF; Mylonakis E; Colombo AL
Antimicrob Agents Chemother; 2015 Oct; 59(10):6581-7. PubMed ID: 26259795
[TBL] [Abstract][Full Text] [Related]
6. Comparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistance.
Singh A; Yadav V; Prasad R
PLoS One; 2012; 7(6):e39812. PubMed ID: 22761908
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of azole antifungals by 2-adamantanamine.
Lafleur MD; Sun L; Lister I; Keating J; Nantel A; Long L; Ghannoum M; North J; Lee RE; Coleman K; Dahl T; Lewis K
Antimicrob Agents Chemother; 2013 Aug; 57(8):3585-92. PubMed ID: 23689724
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
Petraitis V; Petraitiene R; Kelaher AM; Sarafandi AA; Sein T; Mickiene D; Bacher J; Groll AH; Walsh TJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3959-67. PubMed ID: 15388459
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole resistance in Candida albicans is induced by Pseudomonas aeruginosa quorum sensing.
Bandara HMHN; Wood DLA; Vanwonterghem I; Hugenholtz P; Cheung BPK; Samaranayake LP
Sci Rep; 2020 May; 10(1):7769. PubMed ID: 32385378
[TBL] [Abstract][Full Text] [Related]
10. Global proteomic analysis deciphers the mechanism of action of plant derived oleic acid against Candida albicans virulence and biofilm formation.
Muthamil S; Prasath KG; Priya A; Precilla P; Pandian SK
Sci Rep; 2020 Mar; 10(1):5113. PubMed ID: 32198447
[TBL] [Abstract][Full Text] [Related]
11. Sequential Induction of Drug Resistance and Characterization of an Initial
El Hachem S; Fattouh N; Chedraoui C; Finianos M; Bitar I; Khalaf RA
J Fungi (Basel); 2024 May; 10(5):. PubMed ID: 38786702
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin is essential for survival during membrane stress in Candida albicans.
Cruz MC; Goldstein AL; Blankenship JR; Del Poeta M; Davis D; Cardenas ME; Perfect JR; McCusker JH; Heitman J
EMBO J; 2002 Feb; 21(4):546-59. PubMed ID: 11847103
[TBL] [Abstract][Full Text] [Related]
13. Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates.
Borecká S; Pinjon E; Sullivan DJ; Kuchler K; Blaško J; Kulková N; Bujdáková H
Can J Microbiol; 2011 May; 57(5):416-26. PubMed ID: 21542785
[TBL] [Abstract][Full Text] [Related]
14. Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation.
Revie NM; Iyer KR; Maxson ME; Zhang J; Yan S; Fernandes CM; Meyer KJ; Chen X; Skulska I; Fogal M; Sanchez H; Hossain S; Li S; Yashiroda Y; Hirano H; Yoshida M; Osada H; Boone C; Shapiro RS; Andes DR; Wright GD; Nodwell JR; Del Poeta M; Burke MD; Whitesell L; Robbins N; Cowen LE
Nat Commun; 2022 Jun; 13(1):3634. PubMed ID: 35752611
[TBL] [Abstract][Full Text] [Related]
15. Mitigating candidiasis with acarbose by targeting Candida albicans α-glucosidase: in-silico, in-vitro and transcriptomic approaches.
David H; Vasudevan S; Solomon AP
Sci Rep; 2024 May; 14(1):11890. PubMed ID: 38789465
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional responses of
Alves R; Kastora SL; Gomes-Gonçalves A; Azevedo N; Rodrigues CF; Silva S; Demuyser L; Van Dijck P; Casal M; Brown AJP; Henriques M; Paiva S
NPJ Biofilms Microbiomes; 2020; 6():4. PubMed ID: 31993211
[No Abstract] [Full Text] [Related]
17. Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.
Chen T; Yao J; Quan K; Xu J; Hang X; Tong Q; Liu G; Luo P; Zeng L; Feng G; Bi H
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0113123. PubMed ID: 38018962
[TBL] [Abstract][Full Text] [Related]
18. Combining Colistin and Fluconazole Synergistically Increases Fungal Membrane Permeability and Antifungal Cidality.
Bibi M; Murphy S; Benhamou RI; Rosenberg A; Ulman A; Bicanic T; Fridman M; Berman J
ACS Infect Dis; 2021 Feb; 7(2):377-389. PubMed ID: 33471513
[TBL] [Abstract][Full Text] [Related]
19. The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo.
Antoran A; Aparicio-Fernandez L; Pellon A; Buldain I; Martin-Souto L; Rementeria A; Ghannoum MA; Fuchs BB; Mylonakis E; Hernando FL; Ramirez-Garcia A
Sci Rep; 2020 Jun; 10(1):9206. PubMed ID: 32514067
[TBL] [Abstract][Full Text] [Related]
20.
Dumeaux V; Massahi S; Bettauer V; Mottola A; Dukovny A; Khurdia SS; Costa ACBP; Omran RP; Simpson S; Xie JL; Whiteway M; Berman J; Hallett MT
Elife; 2023 Oct; 12():. PubMed ID: 37888959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
